{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:00:48Z","timestamp":1787169648959,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Aragvadhadi Taila<\/jats:italic>\n                      (ART) is one of the herbomineral formulations mentioned in Chakradatta indicated in\n                      <jats:italic toggle=\"yes\">Shwitra<\/jats:italic>\n                      (vitiligo). Modification of\n                      <jats:italic toggle=\"yes\">Taila<\/jats:italic>\n                      form into gel form reduces the risk of contamination in view of arsenical contents (\n                      <jats:italic toggle=\"yes\">Manahshila<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">Haratala<\/jats:italic>\n                      ) assures precise dose administration at desired site (by avoiding spreading). The gel is a comparatively acceptable dosage form than that of medicated oil.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>\n                      The aim of the study is to evaluate the comparative efficacy of\n                      <jats:italic toggle=\"yes\">Aragvadhadi<\/jats:italic>\n                      formulation in\n                      <jats:italic toggle=\"yes\">Taila<\/jats:italic>\n                      (ART:\n                      <jats:italic toggle=\"yes\">Aragvadhadi Taila<\/jats:italic>\n                      ) and gel (ARG:\n                      <jats:italic toggle=\"yes\">Aragvadhadi<\/jats:italic>\n                      gel) dosage forms with the internal administration of\n                      <jats:italic toggle=\"yes\">Rasayana Churna<\/jats:italic>\n                      in the management of\n                      <jats:italic toggle=\"yes\">Shwitra<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods:<\/jats:title>\n                    <jats:p>\n                      The study was a randomized open labeled, involving 66 patients of\n                      <jats:italic toggle=\"yes\">Shwitra<\/jats:italic>\n                      that were randomly divided into two groups. Patients registered in group A (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 34) were treated with local applications of ART and group B (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 32) with ARG for 2 months.\n                      <jats:italic toggle=\"yes\">Rasayana Churna<\/jats:italic>\n                      (3 g), along with the equal quantity of honey and\n                      <jats:italic toggle=\"yes\">Ghrita<\/jats:italic>\n                      was given twice a day after the meal in both groups. Wilcoxon signed-rank test was applied to evaluate the effect of therapy in the individual group for subjective criteria like vitiligo area scoring index score, size and number of patches,\n                      <jats:italic toggle=\"yes\">Rukshata<\/jats:italic>\n                      (dryness),\n                      <jats:italic toggle=\"yes\">Saparidaha<\/jats:italic>\n                      (burning sensation),\n                      <jats:italic toggle=\"yes\">Bahalatva<\/jats:italic>\n                      (thickening),\n                      <jats:italic toggle=\"yes\">Kandu<\/jats:italic>\n                      (itching) while the comparison of results between the groups for the same by applying Coefficient of Variation (CV).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Group B showed better and consistent results in all signs and symptoms except\n                      <jats:italic toggle=\"yes\">Rukshata, Saparidaha<\/jats:italic>\n                      in terms of Coefficient of Variation. In both the groups, statistically highly significant improvement was found in signs and symptoms of\n                      <jats:italic toggle=\"yes\">Shwitra<\/jats:italic>\n                      such as\n                      <jats:italic toggle=\"yes\">Saparidaha, Kandu<\/jats:italic>\n                      , size of patches and number of patches; however, the difference between the groups was statistically insignificant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      Both the forms (ART, ARG) of\n                      <jats:italic toggle=\"yes\">Aragvadhadi<\/jats:italic>\n                      formulation along with\n                      <jats:italic toggle=\"yes\">Rasayana Churna<\/jats:italic>\n                      were found as a safe and effective treatment in vitiligo with significant pigment regeneration capacity as topical use for application over 2 months.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ayu.ayu_323_20","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T05:49:47Z","timestamp":1679809787000},"page":"19-29","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of external application of oil and gel dosage forms of Aragvadhadi formulation in combination with Rasayana Churna in the management of Shwitra (vitiligo) - An open-labeled comparative clinical trial"],"prefix":"10.4103","volume":"42","author":[{"given":"Sarika","family":"Makwana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipali","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Bedarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswajyoti","family":"Patgiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-2-20240901","first-page":"100","article-title":"Vitiligo: Clinical profiles in vadodara","volume":"51","author":"Shajil","year":"2006","journal-title":"Int J Dermatol"},{"key":"R3-2-20240901","first-page":"15","article-title":"Advances in vitiligo: An update on medical and surgical treatments","volume":"10","author":"Dillon","year":"2017","journal-title":"J Clin Aesthet Dermatol"},{"key":"R4-2-20240901","doi-asserted-by":"crossref","first-page":"175","DOI":"10.5144\/0256-4947.1997.175","article-title":"Photochemotherapy for vitiligo: Seven years' experience at a University Hospital","volume":"17","author":"Al-Khawajah","year":"1997","journal-title":"Ann Saudi Med"},{"key":"R5-2-20240901","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4103\/0974-8520.119676","article-title":"Ayurvedic management of adverse drug reactions with shvitrahara varti","volume":"34","author":"Jadav","year":"2013","journal-title":"AYU"},{"key":"R13-2-20240901","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4103\/JISM.JISM_8_20","article-title":"Pharmaceutico-analytical standardization of Aragvadhadi Taila","volume":"7","author":"Makwana","year":"2019","journal-title":"Indian Syst Med"},{"key":"R16-2-20240901","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archderm.140.6.677","article-title":"Parametric modeling of narrowband UV-B phototherapy for vitiligo, using a novel quantitative tool: The Vitiligo Area Scoring Index","volume":"140","author":"Hamzavi","year":"2004","journal-title":"Arch Dermatol"},{"key":"R18-2-20240901","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4103\/0974-8520.175553","article-title":"Clinical efficacy of Apamarga Kshara Yoga in the management of Shvitra (vitiligo)","volume":"36","author":"Jadav","year":"2015","journal-title":"Ayu"},{"key":"R23-2-20240901","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4103\/2229-5178.206122","article-title":"Occupational dermatoses among cottage industry workers of Kashmir valley in north india","volume":"8","author":"Akhtar","year":"2017","journal-title":"Indian Dermatol"},{"key":"R24-2-20240901","first-page":"161","article-title":"Etiopathogenesis of vitiligo: Are we dealing with an environmental disorder?","volume":"65","author":"Bhel","year":"1999","journal-title":"Indian J Dermatol"},{"key":"R28-2-20240901","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/039463201402700403","article-title":"Vitiligo: Symptoms, pathogenesis and treatment","volume":"27","author":"Ghafouriani","year":"2014","journal-title":"Int J Immunopathol Pharmacol"},{"key":"R30-2-20240901","first-page":"73","article-title":"Experimental study on adaptogenic and antiulcer activity of Rasayana Ghana Tablet (A tri-herbal formulation) in albino AQ3 rats","volume":"4","author":"Deole","year":"2013","journal-title":"Indian J Nat Prod Resour"},{"key":"R32-2-20240901","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4103\/0378-6323.159928","article-title":"Vitamin D and skin disease: A review","volume":"81","author":"Wadhwa","year":"2015","journal-title":"Indian J Dermatol Venerol Leprol"},{"key":"R33-2-20240901","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/dth.12410","article-title":"New approach in the treatment of refractory vitiligo: CO2 laser combined with betamethasone and salicylic acid solution","volume":"30","author":"Cunha","year":"2017","journal-title":"Dermatol Ther"},{"key":"R34-2-20240901","first-page":"400","article-title":"Mustard and its uses in Ayurveda","volume":"8","author":"Manohar","year":"2009","journal-title":"Indian J Tradit Knowl"},{"key":"R35-2-20240901","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3889\/oamjms.2018.038","article-title":"Unconventional treatments for vitiligo: Are they satisfactory","volume":"6","author":"Gianfaldoni","year":"2018","journal-title":"Open Access Maced J Med Sci"},{"key":"R36-2-20240901","first-page":"91","article-title":"Clinical efficacy of savarnakara yoga and kanakbinduarishta in th management of shvitra","volume":"23","author":"Shingadiya","year":"2017","journal-title":"J Res Educ India Med"}],"container-title":["AYU (An International Quarterly Journal of Research in Ayurveda)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ayu.AYU_323_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:10:04Z","timestamp":1787166604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ayu.AYU_323_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ayu.ayu_323_20","relation":{},"ISSN":["0974-8520"],"issn-type":[{"value":"0974-8520","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}